Overcoming Melphalan Resistance By Targeting Crucial DNA Repair Pathways in Multiple Myeloma

被引：0
|
作者：
Patel, Pritesh Rajni [1 ]
Senyuk, Vitalyi [1 ]
Sweiss, Karen [2 ]
Calip, Gregory [3 ]
Oh, Annie [1 ]
Mahmud, Nadim [1 ]
Rondelli, Damiano [1 ]
机构：
[1] Univ Illinois, Div Hematol Oncol, Chicago, IL USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60612 USA
[3] Univ Illinois, Coll Pharm, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：S224 / S225
页数：2
相关论文
共 50 条
  • [41] DNA repair pathways in drug resistance in melanoma
    Bradbury, PA
    Middleton, MR
    ANTI-CANCER DRUGS, 2004, 15 (05) : 421 - 426
  • [42] Overcoming adaptive therapy resistance in AML by targeting immune response pathways
    Melgar, Katelyn
    Walker, Morgan M.
    Jones, LaQuita M.
    Bolanos, Lyndsey C.
    Hueneman, Kathleen
    Wunderlich, Mark
    Jiang, Jiang-Kang
    Wilson, Kelli M.
    Zhang, Xiaohu
    Sutter, Patrick
    Wang, Amy
    Xu, Xin
    Choi, Kwangmin
    Tawa, Gregory
    Lorimer, Donald
    Abendroth, Jan
    O'Brien, Eric
    Hoyt, Scott B.
    Berman, Ellin
    Famulare, Christopher A.
    Mulloy, James C.
    Levine, Ross L.
    Perentesis, John P.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (508)
  • [43] Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways
    Melgar, Katelyn M.
    Jones, LaQuita M.
    Walker, Mackenzie
    Bolanos, Lyndsey C.
    Hueneman, Kathleen
    Wunderlich, Mark
    Jiang, Jiang-Kang
    Wilson, Kelli
    Zhang, Xiaohu
    Sutter, Patrick
    Xu, Xin
    Choi, Kwangmin
    Tawa, Gregory
    Lorimer, Donald
    Abendroth, Jan
    O'Brien, Eric
    Hoyt, Scott
    Berman, Ellin
    Famulare, Christopher
    Mulloy, James C.
    Levine, Ross L.
    Rosenbaum, Jan S.
    Perentesis, John P.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2019, 134
  • [44] Actions of aprataxin in multiple DNA repair pathways
    Rass, Ulrich
    Ahel, Ivan
    West, Stephen C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (13) : 9469 - 9474
  • [45] Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments
    Hu, Jingping
    Hu, Wei-Xin
    CANCER LETTERS, 2018, 414 : 214 - 221
  • [46] Overcoming immune resistance in DNA mismatch repair deficient tumors
    Mestrallet, Guillaume
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Proteomic investigation of melphalan resistance in multiple myeloma to support selection of combination therapy
    Xiang, Yun
    Wood, Elizabeth R.
    Gancar, Jessica
    Oguz, Umut
    Cubitt, Christopher L.
    Dalton, William S.
    Shain, Kenneth H.
    Koomen, John M.
    CANCER RESEARCH, 2011, 71
  • [48] Targeting Neddylation to Overcome Drug Resistance in Multiple Myeloma
    Thomas, Gregory S.
    Huang, Junwei
    Zhou, Yi
    Gu, Zhimin
    Yang, Ye
    Xu, Hongwei
    Tricot, Guido J.
    Zhan, Fenghuang
    BLOOD, 2015, 126 (23)
  • [49] Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
    Gourzones, Claire
    Bellanger, Celine
    Lamure, Sylvain
    Gadacha, Ouissem Karmous
    De Paco, Elvira Garcia
    Vincent, Laure
    Cartron, Guillaume
    Klein, Bernard
    Moreaux, Jerome
    CANCERS, 2019, 11 (04):
  • [50] Polymorphisms in DNA repair genes and risk of multiple myeloma
    Rand, Kristin A.
    Conti, David V.
    Haiman, Christopher A.
    Van Den Berg, David J.
    Birmann, Brenda M.
    De Roos, Anneclaire J.
    Severson, Richard K.
    Gebregziabher, Mulugeta
    Ailawadhi, Sikander
    Morbacher, Ann
    Lieber, Michael R.
    Wang, Sophia S.
    Bernstein, Leslie
    Edlund, Christopher K.
    Rothman, Nathaniel
    Chanock, Stephen J.
    Kolonel, Laurence N.
    Colditz, Graham A.
    Munshi, Nikhil
    Anderson, Kenneth C.
    Cozen, Wendy
    CANCER RESEARCH, 2012, 72
12345